Profile
Prof. Niels Halama obtained his MD at the University of Heidelberg, Germany in 2005. He then joined as Resident and Fellow the National Center for Tumor Diseases (NCT). From 2008 till 2016 he was Postdoctoral Research Fellow at the Institute for Immunology and the German Cancer Research Center (DKFZ) in Heidelberg. Since 2017 Niels Halama has been attending the Physician for the Clinical Cancer Research Program “Colorectal Cancer.” In 2018 he got his habilitation in internal medicine at the University of Heidelberg and 2022 he obtained the Award of professorship. From 2019 to 2023 he was leading the department of Translational Immunotherapy at the DKFZ. In 2023 he was appointed W3 professor at the HI-TRON (Helmholtz-Institute for Translational Oncology) in Mainz and is Head of the Division “Tumor Immunology and Tumor Immunotherapy”. He is Chairman of the Scientific Management Board (HI-TRON) and member of the Extended Management Board of the Comprehensive Cancer Center (UCT and UMC).
In addition to running his laboratory, Prof. Niels Halama is Certified clinical investigator in oncology, clinical trials and medical products. 2003 till 2006 he was editor and author of the Section "Endocrinology” and “Neurology", for Medicle (www.medicle.org). He is member of the Deutsche Gesellschaft für Immunologie (DGfI), American Association for Cancer Research (AACR), USA (AACR-sponsored membership), the Cancer Immunology Working Group (CIMM) and the International Cancer Microenvironment Society (ICMS). Prof. Halama is also highly involved in graduate and undergraduate training at the University of Mainz.
His research field is Tumor Immunology, Tumor immunotherapy, Tumor Inflammation, (Immunological) Biomarker Identification, Imaging Technologies, High-Throughput Processing, Colorectal Cancer, Pancreatic cancer, Breast Cancer, Malignant Melanom